Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts()

BACKGROUND AND OBJECTIVES: Chronic rejection leads to kidney allograft failure and develops in many kidney transplant recipients. One cause of chronic rejection, chronic antibody mediated rejection (CAMR), is attributed to alloantibodies. Maintenance immunosuppression including prednisone, mycopheno...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Smith, R. Neal, Malik, Fahim, Goes, Nelson, Farris, Alton B., Zorn, Emmanuel, Saidman, Susan, Tolkoff-Rubin, Nina, Puri, Sonika, Wong, Waichi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3728650/
https://ncbi.nlm.nih.gov/pubmed/22960786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trim.2012.08.005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller